Production (Stage)
ICU Medical, Inc.
ICUI
$128.99
-$1.74-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 604.70M | 629.81M | 589.13M | 596.46M | 566.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 604.70M | 629.81M | 589.13M | 596.46M | 566.66M |
| Cost of Revenue | 394.59M | 402.55M | 384.28M | 389.03M | 381.41M |
| Gross Profit | 210.11M | 227.26M | 204.85M | 207.43M | 185.24M |
| SG&A Expenses | 157.23M | 158.85M | 162.71M | 159.55M | 157.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 575.12M | 583.75M | 568.01M | 571.97M | 560.91M |
| Operating Income | 29.59M | 46.05M | 21.12M | 24.49M | 5.75M |
| Income Before Tax | -10.91M | 8.22M | -17.93M | -19.53M | -36.77M |
| Income Tax Expenses | 4.57M | 32.05M | 15.06M | 1.87M | 2.70M |
| Earnings from Continuing Operations | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.48M | -23.83M | -32.98M | -21.41M | -39.47M |
| EBIT | 29.59M | 46.05M | 21.12M | 24.49M | 5.75M |
| EBITDA | 79.03M | 99.05M | 76.79M | 79.81M | 61.27M |
| EPS Basic | -0.63 | -0.97 | -1.35 | -0.88 | -1.63 |
| Normalized Basic EPS | 0.15 | 0.38 | -0.13 | -0.07 | -0.53 |
| EPS Diluted | -0.63 | -0.98 | -1.35 | -0.88 | -1.63 |
| Normalized Diluted EPS | 0.15 | 0.38 | -0.13 | -0.07 | -0.53 |
| Average Basic Shares Outstanding | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M |
| Average Diluted Shares Outstanding | 24.54M | 24.49M | 24.44M | 24.39M | 24.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |